Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma

Published:2013-12 Issue:6 Volume:36 Page:589-595
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Ranck Mark C.,Golden Daniel W.,Corbin Kimberly S.,Hasselle Michael D.,Liauw Stanley L.,Stadler Walter M.,Hahn Olwen M.,Weichselbaum Ralph R.,Salama Joseph Kamel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference7 articles.

1. The changing natural history of renal cell carcinoma.;Pantuck;J Urol,2001

2. Immunotherapy for metastatic renal cell carcinoma.;Wirth;Urol Clin North Am,1993

3. Oligometastases and oligo-recurrence: the new era of cancer therapy.;Niibe;Jpn J Clin Oncol,2010

4. Oligometastases.;Hellman;J Clin Oncol,1995

5. A rationale for the targeted treatment of oligometastases with radiotherapy.;Macdermed;J Surg Oncol,2008

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR);Cancers;2024-08-25

2. Local Control in Patients with Metastatic Renal Cell Carcinoma to the Spine: The Experience of an Institution with a Multidisciplinary Spine Oncology Program;World Neurosurgery;2023-10

3. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?;Clinical Oncology;2023-03

4. Stereotactic body radiation therapy for kidney cancer. Where do we stand?;International Journal of Urology;2023-02-06

5. Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma;Urologia Internationalis;2022-12-01